Stock ARVEE ARVEE LABORATORIES (INDIA) LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Arvee Laboratories (India) Ltd.

Equities

ARVEE

INE006Z01016

Diversified Chemicals

Market Closed - NSE India S.E.
Other stock markets
 07:43:53 2024-06-14 am EDT 		5-day change 1st Jan Change
196.9 INR +2.84% Intraday chart for Arvee Laboratories (India) Ltd. +2.90% +13.84%
May. 17 Arvee Laboratories Ltd. Reports Earnings Results for the Fourth Quarter Ended March 31, 2024 CI
Mar. 26 Arvee Laboratories Ltd. Announces Resignation of Mr. Dipen Dalal as Independent Director CI

Valuation

Fiscal Period: Marzo 2018 2019 2020 2021 2022 2023
Capitalization 1 335.6 347.1 259 610.5 1,253 969.8
Enterprise Value (EV) 1 477.4 419.9 256.9 612.9 1,238 970.8
P/E ratio 23.6 x 15.3 x 11.6 x 22.8 x 48.7 x 23.5 x
Yield - - - - - -
Capitalization / Revenue 0.73 x 0.63 x 0.57 x 1.29 x 3.11 x 1.58 x
EV / Revenue 1.03 x 0.76 x 0.57 x 1.29 x 3.07 x 1.58 x
EV / EBITDA 6.66 x 6.8 x 4.27 x 10.1 x 21.8 x 13.3 x
EV / FCF 42.3 x 6.84 x 3.73 x -53.5 x 161 x -361 x
FCF Yield 2.36% 14.6% 26.8% -1.87% 0.62% -0.28%
Price to Book 2.36 x 2.11 x 1.39 x 2.85 x 5.23 x 3.46 x
Nbr of stocks (in thousands) 11,020 11,020 11,020 11,020 11,020 11,020
Reference price 2 30.45 31.50 23.50 55.40 113.7 88.00
Announcement Date 9/5/18 7/17/19 8/24/20 8/24/21 5/26/22 8/25/23
1INR in Million2INR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: Marzo 2018 2019 2020 2021 2022 2023
Net sales 1 461.5 549 454.2 473.8 403.3 613.5
EBITDA 1 71.7 61.74 60.13 60.6 56.68 72.73
EBIT 1 50.15 38.24 37.32 36.62 33.56 52.02
Operating Margin 10.87% 6.96% 8.22% 7.73% 8.32% 8.48%
Earnings before Tax (EBT) 1 19.16 25.44 30.91 36.41 34.49 61.65
Net income 1 10.89 22.63 22.27 26.77 25.74 41.19
Net margin 2.36% 4.12% 4.9% 5.65% 6.38% 6.71%
EPS 2 1.290 2.053 2.020 2.430 2.336 3.738
Free Cash Flow 1 11.28 61.35 68.91 -11.45 7.692 -2.692
FCF margin 2.45% 11.17% 15.17% -2.42% 1.91% -0.44%
FCF Conversion (EBITDA) 15.74% 99.37% 114.61% - 13.57% -
FCF Conversion (Net income) 103.61% 271.1% 309.45% - 29.89% -
Dividend per Share - - - - - -
Announcement Date 9/5/18 7/17/19 8/24/20 8/24/21 5/26/22 8/25/23
1INR in Million2INR
Estimates

Balance Sheet Analysis

Fiscal Period: Marzo 2018 2019 2020 2021 2022 2023
Net Debt 1 142 72.8 - 2.4 - 1.08
Net Cash position 1 - - 2.06 - 15 -
Leverage (Debt/EBITDA) 1.978 x 1.178 x - 0.0396 x - 0.0149 x
Free Cash Flow 1 11.3 61.3 68.9 -11.4 7.69 -2.69
ROE (net income / shareholders' equity) 11.8% 14.8% 12.7% 13.3% 11.3% 15.8%
ROA (Net income/ Total Assets) 7.86% 5.88% 6.59% 6.13% 5.26% 8.4%
Assets 1 138.6 384.7 337.8 436.7 489.1 490.1
Book Value Per Share 2 12.90 14.90 17.00 19.50 21.70 25.50
Cash Flow per Share 2 1.780 3.310 0.8900 5.990 4.200 0.4900
Capex 1 13.4 15 22.9 22.9 23.6 14.8
Capex / Sales 2.9% 2.74% 5.03% 4.84% 5.86% 2.42%
Announcement Date 9/5/18 7/17/19 8/24/20 8/24/21 5/26/22 8/25/23
1INR in Million2INR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Diversified Chemicals

1st Jan change Capi.
ARVEE LABORATORIES (INDIA) LTD. Stock Arvee Laboratories (India) Ltd.
+13.84% 25.97M
SHIN-ETSU CHEMICAL CO., LTD. Stock Shin-Etsu Chemical Co., Ltd.
+0.44% 77.9B
BASF SE Stock BASF SE
-7.97% 42.56B
DUPONT DE NEMOURS, INC. Stock DuPont de Nemours, Inc.
+3.55% 33.31B
PIDILITE INDUSTRIES LIMITED Stock Pidilite Industries Limited
+14.54% 18.93B
EASTMAN CHEMICAL COMPANY Stock Eastman Chemical Company
+10.79% 11.7B
BRENNTAG SE Stock Brenntag SE
-22.16% 10.04B
SYENSQO SA/NV Stock Syensqo SA/NV
-6.22% 9.94B
ASAHI KASEI CORPORATION Stock Asahi Kasei Corporation
-3.90% 8.89B
SRF LIMITED Stock SRF Limited
-3.12% 8.53B
Diversified Chemicals
  1. Stock Market
  2. Equities
  3. ARVEE Stock
  4. Financials Arvee Laboratories (India) Ltd.